Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram

Emilio Nardi1, Alessandro Palermo, Giuseppe Mulè

  • 1Dipartimento di Medicina Interna e Specialistica (DIMIS), Excellence Centre of the European Society of Hypertension, Università degli Studi di Palermo, Italy.

Insights

Left ventricular hypertrophy (LVH) is uncommon in hypertensive patients with normal electrocardiograms (ECG) and no other diseases. Longer hypertension duration predicts LVH, suggesting targeted echocardiography for these patients.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Diagnostic Imaging

Background:

  • Electrocardiography (ECG) exhibits limited sensitivity for detecting left ventricular hypertrophy (LVH).
  • Echocardiography, while effective, is not routinely performed for LVH screening.

Purpose of the Study:

  • To determine the prevalence of LVH and diastolic dysfunction in hypertensive patients with normal ECG.
  • To identify predictors of LVH in this specific patient cohort.

Main Methods:

  • 440 hypertensive patients without cardiovascular disease, diabetes, or kidney disease were enrolled.
  • Echocardiography was used to assess LV mass indexed by body surface area (LVMI) and diastolic function.
  • LVH was defined as LVMI >125 g/m² (men) or >110 g/m² (women).

Main Results:

  • The prevalence of LVH was 8.18% in patients with normal ECG.
  • Hypertension duration was the sole independent predictor of LVH (p < 0.001), with an AUC of 0.878.
  • Diastolic dysfunction was detected in only 3.2% of patients.

Conclusions:

  • LVH prevalence is low in hypertensive patients without comorbidities and normal ECG.
  • Patients with echocardiographic LVH had mild elevations in LVMI.
  • Echocardiography may be best reserved for hypertensive patients with longer disease duration.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...